Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study - Samoylenko, Igor V.; Kolontareva, Yulia M.; Kogay, Ekaterina V.; Zhukova, Natalia V.; Utyashev, Igor A.; Ivannikov, Mikhail E.; Menshikov, Konstantin V.; Zinkevich, Maxim V.; Orlova, Kristina V.; Vakhabova, Yulia V.; Volkonsky, Mikhail V.; Beliaeva, Natalia A.; et al. (Frontiers in Oncology, 2024)